Priser
Platform
Blog
Om os
Download
NX Filtration
NX Filtration
Euronext Amsterdam
0

Om

Nx Filtration N.V. is a Dutch company specializing in advanced filtration technology solutions. The primary function of Nx Filtration's patented direct nanofiltration membranes is to purify water by removing micropollutants, including pharmaceuticals, pesticides, and various organic materials. This technology is particularly crucial as it allows for highly efficient water treatment, conserving energy and reducing waste significantly compared to conventional purification methods. Nx Filtration's products have broad applications across multiple industries, including municipal water treatment facilities, industrial water reuse projects, and wastewater treatment plants. By focusing on sustainable and eco-friendly processes, Nx Filtration is playing an essential role in addressing global water scarcity and pollution challenges. The company's innovative approach positions it as a key player in the growing water technology sector, contributing to advancements in sustainable resource management and supporting the push towards more environmentally responsible industrial practices around the world.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I NX FILTRATION MED ENDAVU: Køb NX Filtration ($NXFIL) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i NX Filtration, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerNXFIL
Land
Nederlandene
Antal medarbejdere154
Hjemmesidenxfiltration.com
SektorIndustri
IndustriForurenings- og behandlingskontrol

Analytikerskøn

Baseret på 4 analytikere

Stærkt købKøbHoldSælgStærkt sælg
0%0%75%25%0%